Discontinuation report SANDOZ SENNA S
Report ID | 228268 |
Drug Identification Number | 02247390 |
Brand name | SANDOZ SENNA S |
Common or Proper name | SDZ SENNA S |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | DOCUSATE SODIUM SENNOSIDES |
Strength(s) | 50MG 8.6MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 500FCT BO |
ATC code | A06AB |
ATC description | DRUGS FOR CONSTIPATION |
Reason for discontinuation | Manufacturing issues |
Anticipated discontinuation date | |
Actual discontinuation date | 2024-05-17 |
Remaining supply date | 2024-05-17 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2024-05-18 | English | Compare |
v2 | 2024-05-17 | French | Compare |
v1 | 2024-05-17 | English | Compare |
Showing 1 to 3 of 3